Ganglionat
Internal Medicine
2021-08-04

Ganglionated plexus ablation does not prevent atrial fibrillation better than pulmonary vein isolation

Ganglionated plexus ablation did not prevent atrial fibrillation (AF) better than pulmonary vein isolation (PVI), according to a study presented at the Virtual 2021 Annual Meeting of the Heart Rhythm Society (HRS). In a study of 180 patients, Min-Young Kim, MD, Imperial College London, London, United Kingdom, and colleagues found no significant difference in freedom from atrial arrhythmia lasting more than 30 seconds in the PVI arm (64%) compared with the ganglionated plexus ablation arm (50%) at 12 months (P = .09). The rate of redo ablations was similar for the 50 patients in the PVI a...

Studies ex
Internal Medicine
2021-08-02

Studies examine antibody response in kidney transplant recipients and haemodialysis patients wh...

A study published in JAMA found that a third dose of mRNA-1273 (Moderna) vaccine induced a serologic...

Cardiovasc
Internal Medicine
2021-07-30

Cardiovascular and mortality benefits of sodium-glucose co-transporter-2 inhibitors in patients...

BACKGROUND Evidence from prospective cardiovascular (CV) outcome trials in type 2 diabetes (T2DM) pa...

Videos from category: Cardiology

Effectiven
4:27

Effectiveness and safety of apixaban versus warfarin in obese patients with nonvalvular atrial fibrillation enrolled in medicare and veteran affairs

ACC 2021
PRADA Tria
4:48

PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol

ACC 2021
ADAPTABLE
5:09

ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial

ACC 2021
Inspiratio
7:46

Inspiration-S Double Blind Randomized Controlled Trial: Atorvastatin Versus Placebo In Critically-ill Patients With Covid-19

ACC 2021

Videos from category: Dermatology

Psoriasis
6:51

Psoriasis is a systemic disease

EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

EADV 2020

Videos from category: Diabetology

Accumulate
8:58

Accumulated CV data from SGLT2i outcomes trials

EASD 2020
Remission
10:22

Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology

EASD 2020
Summary of
7:44

Summary of clinical and scientific topics discussed at EASD 2020 congress

EASD 2020
Effects of
11:28

Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial

EASD 2020

Videos from category: Gastroenterology

Duodenal m
11:01

Duodenal mucosal resurfacing shown to discontinue insulin treatment in majority of type 2 diabetes patients and aid weight loss

UEG 2020
Allergy-re
7:48

Allergy-related diseases and IBS

UEG 2020
How to seq
2:20

How to sequence advanced therapies in IBD

ECCO 2020
A Next-Gen
3:06

A Next-Generation, Dual-Action Anti-Integrin Therapy for IBD

ECCO 2020

Videos from category: Hematology

Abelacimab
13:53

Abelacimab for Prevention of Venous Thromboembolism

ISTH 2021
The QUAZAR
13:56

The QUAZAR AML-001 Maintenance Trial

EHA 2021
Novelties
7:52

Novelties in the treatment of Multiple Myeloma

EHA 2021
Idecabtage...
10:25

Idecabtagene vicleucel, a BCMA-​directed CAR T cell therapy, in patients with relapsed and refractory multiple myeloma

EHA 2021

Videos from category: Internal Medicine

Important
8:39

Important messages from EULAR2021: Impact of air pollution on RA flares, effect of COVID-19 on RA care, osteoporosis care of men

EULAR 2021
What is th
14:04

What is the role of transdermal fentanyl patches in management of cancer pain?

PAINWeek 2020
Which are
4:59

Which are the most promising new medications in phase 3 clinical trials for the treatment of painful large joint arthritis?

PAINWeek 2020
Optimising
8:42

Optimising the monitoring and treatment of SSc-ILD

EULAR 2020

Videos from category: Oncology

Expanded e
10:42

Expanded efficacy and safety data from CheckMate 649

ASCO 2021
Current st
8:18

Current state of frontline immunotherapy options in the treatment of NSCLC

ASCO 2021
Clinical d
9:37

Clinical decision making in the treatment of melanoma

ASCO 2021
State of t
7:15

State of the art treatment of prostate cancer

ASCO 2021

Videos from category: Psychiatry

Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021
Consequenc
7:54

Consequences of COVID-19 Outbreak on Mental Health

EPA 2021
Meeting th
15:41

Meeting the challenges of schizophrenia care during the COVID-19 pandemic

EPA 2021

Videos from category: Respiratory

Severe ast
8:04

Severe asthma guidelines: Update 2019

ERS 2019
Resetting
7:38

Resetting the agenda: a new approach to asthma in GINA 2019

ERS 2019
Personalis
5:14

Personalised medicine applied to inhaler selection

ERS 2019
Acute Resp
2:25

Acute Respiratory Failure

ERS 2019

Videos from category: Urology

Balancing
13:20

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma studies

EAU 2021

Suggested videos

By Author
By Topic
By Congress
7:07
KEYNOTE-024 5-year OS update: first-line (1L) pembrolizumab (pembro) vs platinum-based chemotherapy (chemo) in patients (pts) with metastatic NSCLC and PD-L1 tumor proportion score (TPS) ≥50%
ESMO 2020
4:21
Highlights of the 17th St. Gallen International Breast Cancer Conference
St. Gallen BCC 2021
13:09
A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of the International Polycap Study (TIPS)-3
AHA 2020
11:15
EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
ESC 2020
11:06
IMpassion031: Results from a phase III study of neoadjuvant atezolizumab + chemotherapy in early triple-negative breast cancer
ESMO 2020
6:13
Breast cancer highlights from ESMO2020
ESMO 2020
15:58
2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease
ESC 2020
8:49
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma
ASCO 2020
4:48
PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
ACC 2021
15:01
Cardiorenal risk in type 2 diabetes
EASD 2019
6:22
Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study
ASH 2019
16:51
Detailed summary of the Consensus Session of the SG-BCC 2021
St. Gallen BCC 2021
9:01
A Three-arm N-of-1 Trial With Statin, Placebo and Tablet Free Periods, to Verify Side Effects and Identify Their Cause: The SAMSON Trial
AHA 2020
7:44
Summary of clinical and scientific topics discussed at EASD 2020 congress
EASD 2020
3:25
Single cell RNA seq of immune infiltrates
EADO 2019
8:06
ISCHEMIA Trial: Impact Of Completeness Of Revascularization On Clinical Outcomes In Patients With Stable Ischemic Heart Disease Treated With An Invasive Vs. Conservative Strategy
ACC 2021
14:31
ESC Gold Medal 2020 Winner: Kari Stefansson
ESC 2020
9:42
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
St. Gallen BCC 2021
5:09
ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
ACC 2021
13:01
Latest trends, developments in breast surgery
St. Gallen BCC 2021
8:42
Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata
EADV 2019
9:11
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
EHA 2020
7:02
Clinical Impact of Ibrutinib with R-CHOP in Untreated Non-GCB DLBCL Co-Expressing BCL2 and MYC Genes in the Phase 3 Phoenix Trial
ASH 2019
8:34
State of the Science: The Six Pillars of Heart Failure Therapy
AHA 2020
17:43
Recognizing and Addressing Risk in Patients with HR-positive, HER2-negative Early Breast Cancer
St. Gallen BCC 2021
8:36
Why We Should Still Care about Glycemic Lowering Strategies for Type 2 Diabetes
EASD 2019
6:46
The Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia
AHA 2020
11:28
Effects of empagliflozin on physical activity and compensatory appetite responses in people with type 2 diabetes: the SEESAW trial
EASD 2020
20:34
Triple negative breast cancer highlights in ESMO 2020
ESMO 2020
Search by Scientific Content
Search by Congress
Search:
Date
Filters:
Abelacimab
13:53
Title Description

Abelacimab for Prevention of Venous Thromboembolism

Presenter: Jeffrey Weitz
Hematology
ISTH 2021
Expanded e
10:42
Title Description

Expanded efficacy and safety data from CheckMate 649

Presenter: Markus Moehler
Oncology
ASCO 2021
Current st
8:18
Title Description

Current state of frontline immunotherapy options in the treatment of NSCLC

Presenter: Federico Cappuzzo
Oncology
ASCO 2021
The QUAZAR
13:56
Title Description

The QUAZAR AML-001 Maintenance Trial

Presenter: Eytan Stein
Hematology
EHA 2021
Important
8:39
Title Description

Important messages from EULAR2021: Impact of air pollution on RA flares, effect of COVID-19 on RA care, osteoporosis care of men

Presenter: Giovanni Adami
Internal Medicine
EULAR 2021
Balancing
13:20
Title Description

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma studies

Presenter: Jeanny B. Aragon-Ching
Urology
EAU 2021
Clinical d
9:37
Title Description

Clinical decision making in the treatment of melanoma

Presenter: Paolo A. Ascierto
Oncology
ASCO 2021
State of t
7:15
Title Description

State of the art treatment of prostate cancer

Presenter: Oliver Sartor
Oncology
ASCO 2021
State of t
5:21
Title Description

State of the art treatment of breast cancer

Presenter: Virginia G. Kaklamani
Oncology
ASCO 2021
State of t
17:01
Title Description

State of the art treatment of multiple myeloma

Presenter: Andrzej Jakubowiak
Oncology
ASCO 2021
Current st
13:02
Title Description

Current state of immunotherapy options in the treatment of RCC

Presenter: Camillo Porta
Oncology
ASCO 2021
Idecabtage...
10:25
Title Description

Idecabtagene vicleucel, a BCMA-​directed CAR T cell therapy, in patients with relapsed and refractory multiple myeloma

Presenter: Albert Oriol
Hematology
EHA 2021
Novelties
7:52
Title Description

Novelties in the treatment of Multiple Myeloma

Presenter: Enrique Ocio
Hematology
EHA 2021
Effect of
12:51
Title Description

Effect of first-line pembrolizumab treatment in individuals with advanced non-small cell lung cancer and poor performance status.

Presenter: Rajwanth Veluswamy
Oncology
ASCO 2021
Current st
11:17
Title Description

Current state of immunotherapy options in the treatment of melanoma

Presenter: Jeffrey Weber
Oncology
ASCO 2021
Treatment
9:31
Title Description

Treatment of hematological malignancies in 2021

Presenter: Paolo Corradini
Hematology
EHA 2021

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease (CAD): Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients.

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology